Hepatitis B and C rates are significantly increased in certain solid tumors: A large retrospective study

Kocoglu, Hakan; Karaca, Mustafa; Tural, Deniz; Hocaoglu, Erhan; OKUTURLAR, Yıldız; Fetullahoglu, Zeynep; Gunaldi, Meral; Ciftci, Rumeysa; Tuna, Savas; Yuce, Orhan; Ozet, Gulsum; ÖZET, AHMET; Benekli, Mustafa

doi:10.4103/0973-1482.174544

Hepatitis B and C rates are significantly increased in certain solid tumors: A large retrospective study

Copy For Citation

Kocoglu H., Karaca M., Tural D., Hocaoglu E., OKUTURLAR Y., Fetullahoglu Z., ...More

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, vol.14, 2018 (SCI-Expanded)

Publication Type: Article / Article
Volume: 14
Publication Date: 2018
Doi Number: 10.4103/0973-1482.174544
Journal Name: JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Keywords: Cancer, hepatitis B, hepatitis C, prevalence, RECEIVING CYTOTOXIC CHEMOTHERAPY, VIRUS-INFECTION, CANCER-PATIENTS, IMMUNOSUPPRESSIVE THERAPY, AMERICAN SOCIETY, REACTIVATION, RECOMMENDATIONS, SEROPREVALENCE, MALIGNANCIES, REPLICATION
Gazi University Affiliated: Yes

Abstract

Objective: Hepatitis B virus (HBV) and hepatitis C virus (HCV) are associated with significant morbidity and mortality among cancer patients who received cytotoxic chemotherapy. The aim of current study was to elucidate the prevalence of HBV and HCV among large population of solid cancers and lymphoma and to compare them with large number of control group.